查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
人工電子耳市場按組件類型、植入類型、患者類型、最終用戶和地區分類 - 預測至 2030 年
市場調查報告書
商品編碼
1660044

人工電子耳市場按組件類型、植入類型、患者類型、最終用戶和地區分類 - 預測至 2030 年

Cochlear Implants Market by Component Type (Cochlear Implants, Upgrades & Accessories), Type of Implants (Unilateral, Bilateral), Patient Type (Adults, Pediatrics), End User (Hospitals, ENT Clinics) - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 216 Pages | 訂單完成後即時交付

價格

預計 2024 年全球人工電子耳市場價值將達到 28 億美元。

預計預測期內複合年成長率為 9.2%，到 2030 年將達到 47.3 億美元。隨著世界人口老化，與老齡化相關的聽力損失（老年性耳聾）變得越來越普遍，從而增加了接受人工電子耳的潛在候選人的數量。根據世界衛生組織公佈的資料，全球有超過15億人患有聽力損失，佔全球人口的近20%。這些主要因素，即聽力障礙發病率的上升，正在進一步推動對人工電子耳的需求。

研究範圍
調查年份 2022-2030
基準年 2023
預測期 2024-2030
考慮單位 金額（美元）
部分 按組件類型、按植入類型、按患者類型、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、中東和非洲、拉丁美洲、海灣合作理事會國家

2023 年，根據患者類型，小兒科領域將佔據人工電子耳市場的最大佔有率。

成人和兒科構成了人工電子耳市場的患者類型細分。 2023 年，小兒科將佔據人工電子耳市場佔有率的最大佔有率。這主要是由於兒童聽力損失發病率高、技術進步不斷加快、透過新生兒篩檢計畫可以早期發現聽力障礙、以及父母對早期療育益處的認知不斷提高。

根據最終用戶，人工電子耳市場分為醫院、耳鼻喉診所和其他。改善患者治療效果、多學科團隊合作方式以及新的手術技術是醫院採用人工電子耳的驅動力。此外，特別是在新興市場，對醫院基礎設施和人工電子耳保險覆蓋的投資，正在改善人工電子耳人工電子耳的可及性，從而使其變得更加實惠，並增加了醫院環境中的需求。

全球人工電子耳市場分為六個區域：北美、歐洲、亞太、中東和非洲、拉丁美洲和海灣合作理事會國家。預計預測期內亞太地區的人工電子耳市場將成長最快。亞太地區對人工電子耳的需求主要源自於老年人口的增加、亞洲國家 GDP 的上升、亞太國家醫療保健支出的增加以及社會意識的增強。

本報告研究了全球人工電子耳市場，並按組件類型、植入類型、患者類型、最終用戶、區域趨勢和公司概況進行了詳細細分。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章 市場概況

  • 介紹
  • 市場動態
  • 定價分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 波特五力分析
  • 主要相關人員和採購標準
  • 監管分析
  • 貿易分析
  • 專利分析
  • 2025-2026 年重要會議與活動
  • 影響客戶業務的趨勢/干擾
  • 技術分析
  • 投資金籌措場景
  • 人工智慧/生成式人工智慧對人工電子耳市場的影響

第6章人工電子耳市場（依零件類型）

  • 介紹
  • 人工電子耳系統
  • 升級和配件

第 7 章人工電子耳市場（依植入類型）

  • 介紹
  • 單側植入
  • 雙側植入

第 8 章人工電子耳市場（依患者類型）

  • 介紹
  • 成人
  • 孩子們

第 9 章人工電子耳市場（依最終使用者）

  • 介紹
  • 醫院
  • 耳鼻喉科診所
  • 其他

第 10 章人工電子耳市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 專注於現代化醫療體系和提高政府意識提升以推動市場
    • 中東和非洲宏觀經濟展望
  • 海灣合作理事會國家
    • 重點關注基礎設施建設和醫療保健，以支持市場成長
    • 海灣合作理事會國家的宏觀經濟展望

第11章 競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 2021-2023 年收益分析
  • 2023 年市場佔有率分析
  • 公司估值矩陣：主要參與企業，2023 年
  • 估值及財務指標
  • 品牌/產品比較
  • 競爭場景

第12章 公司簡介

  • 主要參與企業
    • COCHLEAR LTD.
    • SONOVA
    • MED-EL MEDICAL ELECTRONICS
    • ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
    • NEUBIO AG
    • TODOC CO., LTD.
    • SHANGHAI LISTENT MEDICAL TECH CO., LTD.

第13章 附錄

Product Code: MD 9284

The global cochlear implants market is valued at an estimated 2.80 billion in 2024 and is projected to reach USD 4.73 billion by 2030, at a CAGR of 9.2% during the forecast period. With the global increase in aging populations, age-related hearing loss (presbycusis) is becoming more common, creating a larger pool of potential candidates for cochlear implantation. WHO-reported data suggests that over 1.5 billion people-just under 20% of the global population-with hearing loss existed, of which around 430 million have disabling hearing loss, and are expected to rise by more than double-750 million in 2050. The main driver of these growth factors, the rising incidence of hearing problems, fuels further demand for CI.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD)
SegmentsComponent Type, Type of Implants, Patient Type, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries

In 2023, the pediatric segment accounted for the largest share of the cochlear implants market, by patient type.

Adults and pediatrics make up the patient type-based segments of the cochlear implants market. Market share for cochlear implants was highest in the peadiatrics in 2023. This is mainly due to the high incidence of hearing loss in children, increasing technological advancements, early diagnosis of hearing impairments through newborn screening programs, and growing awareness among parents about the benefits of early intervention.

"The hospitals segment is projected to witness the highest growth rate in the cochlear implants market, by end user, during the forecast period."

Based on end user, the cochlear implants market is segmented into hospitals, ENT clinics, and other end users. The driving factors that force hospitals to adopt cochlear implants include better patient outcomes, a multidisciplinary team approach, and novel surgical technologies. Besides, investment in hospital infrastructure-especially within emerging markets-and insurance cover for cochlear implants ensure better access and, consequently, better affordability of cochlear implants, increasing their demand in the hospital environment.

"The Asia Pacific region is projected to witness highest growth rate in the cochlear implants market during the forecast period"

The global cochlear implants market is segmented into six regions - North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the cochlear implants market is expected to grow at the fastest rate in the Asia Pacific region. The demand for cochlear implants in the APAC is mainly driven by the growing geriatric population, the increasing GDP of Asian countries, the rising healthcare expenditure in the APAC countries, and growing public awareness.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 35%, Europe - 31%, Asia Pacific - 22%, Latin America - 9%, Middle East & Africa - 2%, and the GCC Countries - 1%

Lists of Companies Profiled in the Report:

Cochlear Ltd. (Australia), Sonova (Switzerland), MED-EL Medical Electronics (Austria), Zhejiang Nurotron Biotechnology Co., Ltd. (China), Neubio AG (Switzerland), TODOC Co., Ltd. (South Korea), and Shanghai Listent Medical Tech Co., Ltd. (China).

Research Coverage:

In this report, the cochlear implants market has been categorized based on type of implants (unilateral implants, bilateral implants), end user (hospitals, ENT clinics, and other end users), patient type (adults, pediatrics), component type (cochlear implant systems, upgrades & accessories), and region (Europe, Middle East & Africa, North America, Latin America, Asia Pacific, and the GCC Countries).

Comprehensive information regarding the main drivers, barriers, opportunities, and challenges influencing the cochlear implants market's expansion is included in detail in this study. An exhaustive study of the key players in the cochlear implants market has been done to provide insights into their business profile, products offered, noteworthy strategies, product launches and approvals, and other recent activities pertaining to the market.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall cochlear implants market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, challenges, opportunities, and restaints.

The report provides insights on the following pointers:

  • Analysis of key drivers: (Rising prevalence of hearing impairment, growing geriatric population, and comprehensive insurance coverage and favorable reimbursement policies), restraints (High cost of cochlear implants and associated surgeries and surgical risks, procedural complications, and long post-surgery rehabilitation), opportunities (Lucrative growth opportunities in emerging economies, technological innovations in cochlear implants, and integration with digital health platforms), and challenges (Shortage of skilled professionals performing ENT procedures, competition from alternative solutions) influencing the growth of the in cochlear implants market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the cochlear implants market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cochlear implants market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Cochlear Ltd. (Australia), Sonova (Switzerland), and MED-EL Medical Electronics (Austria) are among others, in the cochlear implants market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources for secondary data
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Objectives of primary research
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Key industry insights
      • 2.1.2.5 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Company revenue estimation approach
        • 2.2.1.1.1 Presentations of companies and primary interviews
        • 2.2.1.1.2 Primary interviews
        • 2.2.1.1.3 Country-based approach for estimating global market size
        • 2.2.1.1.4 Approach for estimating global market size based on units sold
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
    • 2.5.1 MARKET ASSUMPTIONS
    • 2.5.2 GROWTH RATE ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 COCHLEAR IMPLANTS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE AND COUNTRY (2023)
  • 4.3 COCHLEAR IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 COCHLEAR IMPLANTS MARKET: REGIONAL MIX (2024-2030)
  • 4.5 COCHLEAR IMPLANTS MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of hearing impairment
      • 5.2.1.2 Growing geriatric population
      • 5.2.1.3 Comprehensive insurance coverage and favorable reimbursement policies
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of cochlear implants and associated surgeries
      • 5.2.2.2 Surgical risks, procedural complications, and long post-surgery rehabilitation
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Lucrative growth opportunities in emerging economies
      • 5.2.3.2 Technological innovations in cochlear implants
      • 5.2.3.3 Integration with digital health platforms
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals performing ENT procedures
      • 5.2.4.2 Competition from alternative solutions
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT SYSTEMS, BY REGION, 2021-2023
    • 5.3.2 AVERAGE SELLING PRICE TREND COCHLEAR IMPLANT PRODUCTS, BY KEY PLAYER, 2021-2023
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    • 5.6.1 ROLE IN ECOSYSTEM
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.8.2 KEY BUYING CRITERIA
  • 5.9 REGULATORY ANALYSIS
    • 5.9.1 REGULATORY FRAMEWORK
      • 5.9.1.1 North America
        • 5.9.1.1.1 US
        • 5.9.1.1.2 Canada
      • 5.9.1.2 Europe
      • 5.9.1.3 Asia Pacific
        • 5.9.1.3.1 Japan
        • 5.9.1.3.2 China
        • 5.9.1.3.3 India
      • 5.9.1.4 Latin America
        • 5.9.1.4.1 Brazil
        • 5.9.1.4.2 Mexico
      • 5.9.1.5 Middle East
      • 5.9.1.6 Africa
    • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA FOR HS CODE 902140
    • 5.10.2 EXPORT DATA FOR HS CODE 902140
  • 5.11 PATENT ANALYSIS
    • 5.11.1 LIST OF MAJOR PATENTS
  • 5.12 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.14 TECHNOLOGY ANALYSIS
    • 5.14.1 KEY TECHNOLOGIES
      • 5.14.1.1 Electrode-based auditory nerve stimulation
    • 5.14.2 COMPLEMENTARY TECHNOLOGIES
      • 5.14.2.1 Bimodal hearing solutions
    • 5.14.3 ADJACENT TECHNOLOGIES
      • 5.14.3.1 Bone conduction hearing devices
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 IMPACT OF AI/GEN AI ON COCHLEAR IMPLANTS MARKET

6 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE

  • 6.1 INTRODUCTION
  • 6.2 COCHLEAR IMPLANT SYSTEMS
    • 6.2.1 INCREASED GERIATRIC POPULATION AND AVAILABILITY OF MEDICAL INSURANCE TO BOOST MARKET GROWTH
  • 6.3 UPGRADES & ACCESSORIES
    • 6.3.1 FOCUS ON TECHNOLOGICAL INNOVATIONS AND DEVICE PERSONALIZATION TO PROPEL MARKET GROWTH

7 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT

  • 7.1 INTRODUCTION
  • 7.2 UNILATERAL IMPLANTS
    • 7.2.1 BETTER INSURANCE COVERAGE TO AID ADOPTION OF UNILATERAL IMPLANTS IN PATIENTS
  • 7.3 BILATERAL IMPLANTS
    • 7.3.1 IMPROVED SOUND LOCALIZATION AND SPEECH COMPREHENSION IN NOISY ENVIRONMENTS AMONG CHILDREN TO AUGMENT GROWTH

8 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE

  • 8.1 INTRODUCTION
  • 8.2 ADULTS
    • 8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS IN GERIATRIC POPULATION TO FUEL ADOPTION OF COCHLEAR IMPLANTS
  • 8.3 PEDIATRICS
    • 8.3.1 EARLY DIAGNOSIS OF HEARING IMPAIRMENTS THROUGH NEWBORN SCREENING PROGRAMS TO SUPPORT MARKET GROWTH

9 COCHLEAR IMPLANTS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    • 9.2.1 INCREASED ACCESS TO ADVANCED DIAGNOSTIC EQUIPMENT AND PRESENCE OF SKILLED SURGICAL TEAMS TO AID MARKET GROWTH
  • 9.3 ENT CLINICS
    • 9.3.1 INCREASING AWARENESS OF ENT-RELATED ISSUES AND GROWING NETWORK OF ADVANCED CLINICS TO AID GROWTH
  • 9.4 OTHER END USERS

10 COCHLEAR IMPLANTS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 US to dominate North American cochlear implants market during study period
    • 10.2.3 CANADA
      • 10.2.3.1 Growing geriatric population and rising government health expenditure to propel market growth
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 High incidence of hearing impairment and favorable government health insurance schemes to augment growth
    • 10.3.3 UK
      • 10.3.3.1 Increased prevalence of hearing problems among older adults to boost market growth
    • 10.3.4 FRANCE
      • 10.3.4.1 Need for advanced treatment options and high government healthcare expenditure to spur market adoption
    • 10.3.5 ITALY
      • 10.3.5.1 Well-developed healthcare system with high financial resources to fuel uptake of cochlear implants
    • 10.3.6 SPAIN
      • 10.3.6.1 Long waiting times for ENT appointments and lack of reimbursement to limit market growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 JAPAN
      • 10.4.2.1 Advanced healthcare system and rapidly growing geriatric population to support market growth
    • 10.4.3 CHINA
      • 10.4.3.1 Modernization of healthcare facilities and increased patient pool to drive market
    • 10.4.4 INDIA
      • 10.4.4.1 Higher incidence of hearing impairment and increased government funds to propel market growth
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Increasing number of ENT specialists and rising government funding in public hospitals to support market growth
    • 10.4.6 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Favorable investment scenario from medical device manufacturers to favor market growth
    • 10.5.3 MEXICO
      • 10.5.3.1 Increased FDI and growing presence of key healthcare companies to support market growth
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 FOCUS ON HEALTHCARE SYSTEM MODERNIZATION AND INCREASED GOVERNMENT AWARENESS TO DRIVE MARKET
    • 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.7 GCC COUNTRIES
    • 10.7.1 EMPHASIS ON INFRASTRUCTURAL DEVELOPMENT AND HEALTHCARE ACCESS TO SUPPORT MARKET GROWTH
    • 10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN COCHLEAR IMPLANTS MARKET
  • 11.3 REVENUE ANALYSIS, 2021-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Component type footprint
      • 11.5.5.4 Patient type footprint
      • 11.5.5.5 End-user footprint
  • 11.6 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7 BRAND/PRODUCT COMPARISON
  • 11.8 COMPETITIVE SCENARIO
    • 11.8.1 PRODUCT LAUNCHES & APPROVALS
    • 11.8.2 DEALS
    • 11.8.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 COCHLEAR LTD.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches & approvals
        • 12.1.1.3.2 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 SONOVA
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Other developments
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 MED-EL MEDICAL ELECTRONICS
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches
        • 12.1.3.3.2 Deals
        • 12.1.3.3.3 Other developments
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
    • 12.1.5 NEUBIO AG
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
    • 12.1.6 TODOC CO., LTD.
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
    • 12.1.7 SHANGHAI LISTENT MEDICAL TECH CO., LTD.
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 COCHLEAR IMPLANTS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 COCHLEAR IMPLANTS MARKET: KEY DATA FROM PRIMARY SOURCES
  • TABLE 3 COCHLEAR IMPLANTS MARKET: MARKET ASSUMPTIONS
  • TABLE 4 COCHLEAR IMPLANTS MARKET: RISK ASSESSMENT
  • TABLE 5 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2023 VS. 2030 VS. 2050
  • TABLE 6 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT SYSTEMS, BY REGION, 2021-2023
  • TABLE 7 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT PRODUCTS, BY KEY PLAYER, 2021-2023
  • TABLE 8 COCHLEAR IMPLANTS MARKET: ROLE IN ECOSYSTEM
  • TABLE 9 COCHLEAR IMPLANTS MARKET: PORTER'S FIVE FORCES
  • TABLE 10 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 11 KEY BUYING CRITERIA FOR MAJOR END USERS
  • TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 IMPORT DATA FOR HS CODE 902140, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 23 EXPORT DATA FOR HS CODE 902140, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 24 COCHLEAR IMPLANTS MARKET: LIST OF MAJOR PATENTS
  • TABLE 25 COCHLEAR IMPLANTS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 26 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 27 KEY COCHLEAR IMPLANT SYSTEMS AVAILABLE IN MARKET
  • TABLE 28 COCHLEAR IMPLANT SYSTEMS MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 29 NORTH AMERICA: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 30 EUROPE: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 32 LATIN AMERICA: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 33 KEY COCHLEAR IMPLANT UPGRADES & ACCESSORIES AVAILABLE IN MARKET
  • TABLE 34 COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 35 NORTH AMERICA: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 36 EUROPE: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 38 LATIN AMERICA: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 39 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 40 COCHLEAR UNILATERAL IMPLANTS MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 41 NORTH AMERICA: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 42 EUROPE: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 44 LATIN AMERICA: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 45 COCHLEAR BILATERAL IMPLANTS MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 47 EUROPE: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 49 LATIN AMERICA: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 50 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 51 COCHLEAR IMPLANTS MARKET FOR ADULTS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 52 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 53 EUROPE: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 55 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 56 COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 57 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 58 EUROPE: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 60 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 61 COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 62 COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 64 EUROPE: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 66 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 67 COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 69 EUROPE: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 71 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 72 COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 73 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 74 EUROPE: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 76 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 77 HEARING AIDS SOLD GLOBALLY, 2022-2030 (MILLION UNITS)
  • TABLE 78 COCHLEAR IMPLANTS MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 80 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 83 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030(USD MILLION)
  • TABLE 84 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 85 US: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 86 US: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 87 US: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 88 US: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 89 CANADA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 90 CANADA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 91 CANADA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 92 CANADA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 93 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 94 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 95 EUROPE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 96 EUROPE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 97 EUROPE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 98 EUROPE: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 99 GERMANY: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 100 GERMANY: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 101 GERMANY: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 102 GERMANY: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 103 UK: NUMBER OF NEW COCHLEAR IMPLANT RECIPIENTS
  • TABLE 104 UK: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 105 UK: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 106 UK: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 107 UK: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 108 FRANCE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 109 FRANCE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 110 FRANCE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 111 FRANCE: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 112 ITALY: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 113 ITALY: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 114 ITALY: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 115 ITALY: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 116 SPAIN: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 117 SPAIN: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 118 SPAIN: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 119 SPAIN: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 120 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 121 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 122 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 123 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 125 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 130 JAPAN: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 131 JAPAN: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 132 JAPAN: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 133 JAPAN: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 134 CHINA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 135 CHINA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 136 CHINA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 137 CHINA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 138 INDIA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 139 INDIA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 140 INDIA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 141 INDIA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 142 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 143 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 144 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 145 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 146 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 147 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 148 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 149 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 150 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 151 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 152 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 153 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 154 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 155 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 156 BRAZIL: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 157 BRAZIL: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 158 BRAZIL: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 159 BRAZIL: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 160 MEXICO: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 161 MEXICO: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 162 MEXICO: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 163 MEXICO: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 164 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 165 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 166 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 167 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 169 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 172 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 173 GCC COUNTRIES: MACROECONOMIC INDICATORS
  • TABLE 174 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022-2030 (USD MILLION)
  • TABLE 176 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 177 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 178 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS IN COCHLEAR IMPLANTS MARKET
  • TABLE 179 COCHLEAR IMPLANTS MARKET: DEGREE OF COMPETITION
  • TABLE 180 COCHLEAR IMPLANTS MARKET: REGION FOOTPRINT
  • TABLE 181 COCHLEAR IMPLANTS MARKET: COMPONENT TYPE FOOTPRINT
  • TABLE 182 COCHLEAR IMPLANTS MARKET: PATIENT TYPE FOOTPRINT
  • TABLE 183 COCHLEAR IMPLANTS MARKET: END-USER FOOTPRINT
  • TABLE 184 COCHLEAR IMPLANTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 185 COCHLEAR IMPLANTS MARKET: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 186 COCHLEAR IMPLANTS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-DECEMBER 2024
  • TABLE 187 COCHLEAR LTD.: COMPANY OVERVIEW
  • TABLE 188 COCHLEAR LTD.: PRODUCTS OFFERED
  • TABLE 189 COCHLEAR LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 190 COCHLEAR LTD.: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 191 SONOVA: COMPANY OVERVIEW
  • TABLE 192 EXCHANGE RATES USED FOR CONVERSION OF CHF TO USD
  • TABLE 193 SONOVA: PRODUCTS OFFERED
  • TABLE 194 SONOVA: OTHER DEVELOPMENTS, JANUARY 2021-DECEMBER 2024
  • TABLE 195 MED-EL MEDICAL ELECTRONICS: COMPANY OVERVIEW
  • TABLE 196 MED-EL MEDICAL ELECTRONICS: PRODUCTS OFFERED
  • TABLE 197 MED-EL MEDICAL ELECTRONICS: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
  • TABLE 198 MED-EL MEDICAL ELECTRONICS: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 199 MED-EL MEDICAL ELECTRONICS: OTHER DEVELOPMENTS, JANUARY 2021-DECEMBER 2024
  • TABLE 200 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 201 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 202 NEUBIO AG: COMPANY OVERVIEW
  • TABLE 203 NEUBIO AG: PRODUCTS OFFERED
  • TABLE 204 TODOC CO., LTD.: COMPANY OVERVIEW
  • TABLE 205 TODOC CO., LTD.: PRODUCTS OFFERED
  • TABLE 206 SHANGHAI LISTENT MEDICAL TECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 207 SHANGHAI LISTENT MEDICAL TECH CO., LTD.: PRODUCTS OFFERED

List of Figures

  • FIGURE 1 COCHLEAR IMPLANTS MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
  • FIGURE 2 COCHLEAR IMPLANTS MARKET: YEARS CONSIDERED
  • FIGURE 3 COCHLEAR IMPLANTS MARKET: RESEARCH DESIGN
  • FIGURE 4 COCHLEAR IMPLANTS MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 COCHLEAR IMPLANTS MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 COCHLEAR IMPLANTS MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 7 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 8 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 COCHLEAR IMPLANTS MARKET: REVENUE SHARE ANALYSIS
  • FIGURE 10 COUNTRY-BASED APPROACH FOR ESTIMATING GLOBAL MARKET SIZE
  • FIGURE 11 COCHLEAR IMPLANTS MARKET: APPROACH FOR ESTIMATING GLOBAL MARKET SIZE BASED ON UNITS SOLD
  • FIGURE 12 COCHLEAR IMPLANTS MARKET: CAGR PROJECTIONS (SUPPLY SIDE)
  • FIGURE 13 COCHLEAR IMPLANTS MARKET: TOP-DOWN APPROACH
  • FIGURE 14 COCHLEAR IMPLANTS MARKET: DATA TRIANGULATION
  • FIGURE 15 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 COCHLEAR IMPLANTS MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 19 COCHLEAR IMPLANTS MARKET: REGIONAL SNAPSHOT
  • FIGURE 20 INCREASING PATIENT POOL AND RISING HEALTHCARE EXPENDITURE TO DRIVE MARKET
  • FIGURE 21 US AND COCHLEAR IMPLANT SYSTEMS COMMANDED LARGEST MARKET SHARE IN 2023
  • FIGURE 22 CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030
  • FIGURE 23 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING STUDY PERIOD
  • FIGURE 24 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 25 COCHLEAR IMPLANTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 COCHLEAR IMPLANTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 COCHLEAR IMPLANTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 28 COCHLEAR IMPLANTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 KEY PLAYERS IN COCHLEAR IMPLANTS MARKET ECOSYSTEM
  • FIGURE 30 COCHLEAR IMPLANTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 32 KEY BUYING CRITERIA FOR MAJOR END USERS
  • FIGURE 33 PATENT ANALYSIS FOR COCHLEAR IMPLANTS, JANUARY 2014-DECEMBER 2024
  • FIGURE 34 COCHLEAR IMPLANTS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • FIGURE 35 COCHLEAR IMPLANTS MARKET: FUNDING AND NUMBER OF DEALS, 2020-2024
  • FIGURE 36 NORTH AMERICA: COCHLEAR IMPLANTS MARKET SNAPSHOT
  • FIGURE 37 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET SNAPSHOT
  • FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN COCHLEAR IMPLANTS MARKET, 2021-2023
  • FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN COCHLEAR IMPLANTS MARKET (2023)
  • FIGURE 40 COCHLEAR IMPLANTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 41 COCHLEAR IMPLANTS MARKET: COMPANY FOOTPRINT
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 COCHLEAR IMPLANTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 45 COCHLEAR LTD.: COMPANY SNAPSHOT
  • FIGURE 46 SONOVA: COMPANY SNAPSHOT